Glaukos (GKOS) Reports Q3 Loss, Tops Revenue Estimates

Glaukos (GKOS) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of$ 0.52. This compares to loss of $0.50 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 46.15%. A quarter ago, it was expected that this glaucoma treatments developer would post a loss of$ 0.52 per share when it actually produced a loss of $0.52, delivering no surprise.Over the last four quarters, the company has sur ...